BioLargo Statistics
Total Valuation
BioLargo has a market cap or net worth of 43.38 million. The enterprise value is 42.94 million.
| Market Cap | 43.38M |
| Enterprise Value | 42.94M |
Important Dates
The last earnings date was Friday, May 22, 2026.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioLargo has 319.36 million shares outstanding. The number of shares has increased by 3.82% in one year.
| Current Share Class | 319.36M |
| Shares Outstanding | 319.36M |
| Shares Change (YoY) | +3.82% |
| Shares Change (QoQ) | +1.40% |
| Owned by Insiders (%) | 13.68% |
| Owned by Institutions (%) | 0.04% |
| Float | 252.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.73 |
| PB Ratio | -231.96 |
| P/TBV Ratio | 24.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.33 |
| EV / Sales | 7.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.54 |
Financial Position
The company has a current ratio of 1.10
| Current Ratio | 1.10 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.60 |
| Interest Coverage | -25.49 |
Financial Efficiency
Return on equity (ROE) is -680.11% and return on invested capital (ROIC) is -148.58%.
| Return on Equity (ROE) | -680.11% |
| Return on Assets (ROA) | -106.04% |
| Return on Invested Capital (ROIC) | -148.58% |
| Return on Capital Employed (ROCE) | -445.44% |
| Weighted Average Cost of Capital (WACC) | 4.33% |
| Revenue Per Employee | 124,689 |
| Profits Per Employee | -286,911 |
| Employee Count | 46 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 9.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.14% in the last 52 weeks. The beta is -0.09, so BioLargo's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -34.14% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 44.17 |
| Average Volume (20 Days) | 478,878 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioLargo had revenue of 5.61 million and -12.91 million in losses. Loss per share was -0.04.
| Revenue | 5.61M |
| Gross Profit | 2.38M |
| Operating Income | -16.18M |
| Pretax Income | -16.67M |
| Net Income | -12.91M |
| EBITDA | -16.05M |
| EBIT | -16.18M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 4.12 million in cash and 5.66 million in debt, with a net cash position of -1.54 million or -0.00 per share.
| Cash & Cash Equivalents | 4.12M |
| Total Debt | 5.66M |
| Net Cash | -1.54M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -187,000 |
| Book Value Per Share | 0.01 |
| Working Capital | 513,000 |
Cash Flow
In the last 12 months, operating cash flow was -9.38 million and capital expenditures -78,000, giving a free cash flow of -9.46 million.
| Operating Cash Flow | -9.38M |
| Capital Expenditures | -78,000 |
| Depreciation & Amortization | 137,000 |
| Net Borrowing | 3.09M |
| Free Cash Flow | -9.46M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 42.35%, with operating and profit margins of -288.42% and -230.10%.
| Gross Margin | 42.35% |
| Operating Margin | -288.42% |
| Pretax Margin | -297.15% |
| Profit Margin | -230.10% |
| EBITDA Margin | -285.97% |
| EBIT Margin | -288.42% |
| FCF Margin | n/a |
Dividends & Yields
BioLargo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.82% |
| Shareholder Yield | -3.82% |
| Earnings Yield | -29.77% |
| FCF Yield | -21.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |